Streetbeat News

Analyst Ratings

QDEL

UBS analyst John Sourbeer has upgraded QuidelOrtho (NASDAQ:QDEL) from Sell to Neutral and increased the price target from $42 to $50.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 7:04 pm

WKC

In the past three months, analysts have provided mixed ratings for World Kinect (NYSE:WKC), with a range of price targets from $27 to $33. The average price target increased to $30, up 3.45% from the previous $29. Analysts' actions include raising, maintaining, and lowering ratings, reflecting varied expectations for the company's future performance.

Portfolio Pulse from Benzinga Insights

September 19, 2024 | 7:03 pm

CBUS

Cibus (NASDAQ:CBUS) has received bullish ratings from 4 analysts over the past three months, with a positive shift in average price targets. The company's financial performance shows strong revenue growth and effective debt management, despite negative net margins and returns. Analysts have adjusted their price targets, reflecting evolving market conditions.

Portfolio Pulse from Benzinga Insights

September 19, 2024 | 7:03 pm

ABT

Piper Sandler initiated coverage on Abbott Laboratories (NYSE:ABT) with an Overweight rating and a price target of $131, citing its attractive valuation and strong growth prospects in the medtech sector. Despite ongoing litigation, Abbott's diversified business model and consistent dividend payments make it a top large-cap medtech company.

Portfolio Pulse from Vandana Singh

September 19, 2024 | 7:03 pm

AA

UBS analyst Curt Woodworth maintains a Buy rating on Alcoa (NYSE:AA) and raises the price target from $38 to $40.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 7:02 pm

PLCE

UBS analyst Jay Sole maintains a Neutral rating on Children's Place (NASDAQ:PLCE) but raises the price target from $12 to $18.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 7:00 pm

EXEL

UBS has initiated coverage on Exelixis with a Neutral rating and set a price target of $30.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 6:57 pm

HUBS

ZI

Piper Sandler analyst Brent Bracelin maintains an Overweight rating on HubSpot (HUBS) with a $570 price target, citing AI innovations and strong retention. Despite macroeconomic headwinds, HubSpot is expected to gain market share and improve customer spending growth. The company is expanding rapidly, with new AI products and a revised operating margin target. ZoomInfo (ZI) may face SMB churn.

Portfolio Pulse from Anusuya Lahiri

September 19, 2024 | 6:48 pm

TRUP

Trupanion (NASDAQ:TRUP) has been analyzed by five analysts, all of whom have given an 'Indifferent' rating. The average 12-month price target has increased by 28.06% to $35.6, with a high of $45.00 and a low of $30.00. Analysts have raised their price targets, reflecting a more positive outlook despite Trupanion's financial challenges, such as low net margin and ROE.

Portfolio Pulse from Benzinga Insights

September 19, 2024 | 6:46 pm

AVY

Avery Dennison (NYSE:AVY) has been evaluated by 7 analysts over the past three months, with ratings ranging from bullish to bearish. The average 12-month price target is $252.37, slightly down from $252.50. Analysts have adjusted their ratings and price targets, reflecting evolving market conditions. Avery Dennison has shown revenue growth but faces challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

September 19, 2024 | 6:45 pm